Myeloperoxidase Overexpression in Children with Hypercholesterolemia
Overview
Authors
Affiliations
Background: Studies conducted in healthy children showed that biomarkers of oxidative stress decreased with increasing age from 1 to 11 years. No data have been reported concerning the behavior of age-related oxidative stress in hypercholesterolemic children.
Objective: Aim of this study was to test if children with hypercholesterolemia have prolonged exposure to enhanced oxidative stress and to study the underlying mechanism.
Methods: We performed a cross-sectional study comparing 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels in 95 normocholesterolemic and 95 hypercholesterolemic children.
Results: Compared to normocholesterolemic children, those with hypercholesterolemia had higher 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels. A correlation analysis of the overall population showed that total cholesterol was directly correlated with 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase. Stepwise linear regression showed that only total cholesterol, 8-hydroxy-2'deoxyguanosine and myeloperoxidase levels predicted oxidized-LDL plasma levels. In normocholesterolemic children oxidized-LDL and myeloperoxidase plasma levels significantly decreased from first (1-5 years) to second (6-9 years) quartile of age. In hypercholesterolemic children 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels did not show significant differences among quartiles of age.
Conclusion: This study shows that an early and persistent oxidative stress is detected in hypercholesterolemic children and that myeloperoxidase up-regulation might play a role.
Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits.
Nour O, Shehatou G, Rahim M, El-Awady M, Suddek G Naunyn Schmiedebergs Arch Pharmacol. 2018; 391(11):1203-1219.
PMID: 30058017 DOI: 10.1007/s00210-018-1547-8.
Association between Myeloperoxidase Levels and Risk of Insulin Resistance in Egyptian Obese Women.
Zaki M, Basha W, Reyad H, Mohamed R, Hassan N, Kholousi S Open Access Maced J Med Sci. 2018; 6(4):629-633.
PMID: 29731928 PMC: 5927491. DOI: 10.3889/oamjms.2018.164.
Vascular endothelial dysfunction and pharmacological treatment.
Su J World J Cardiol. 2015; 7(11):719-41.
PMID: 26635921 PMC: 4660468. DOI: 10.4330/wjc.v7.i11.719.
Macknin M, Kong T, Weier A, Worley S, Tang A, Alkhouri N J Pediatr. 2015; 166(4):953-9.e1-3.
PMID: 25684089 PMC: 4380801. DOI: 10.1016/j.jpeds.2014.12.058.
Olza J, Aguilera C, Gil-Campos M, Leis R, Bueno G, Martinez-Jimenez M Diabetes Care. 2012; 35(11):2373-6.
PMID: 22912422 PMC: 3476926. DOI: 10.2337/dc12-0614.